A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials (2018)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2018.01.006
PubMed Identifier: 29552576
Publication URI: http://europepmc.org/abstract/MED/29552576
Type: Journal Article/Review
Parent Publication: Molecular Therapy - Methods & Clinical Development
ISSN: 2329-0501